Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Hangzhou Genlight Neurotech Co. Ltd. is currently managing 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This prosecution is focused, involving 1 distinct examiner, SISON, CHRISTINE ANDREA PAN. As the busiest examiner for the company, SISON, CHRISTINE ANDREA PAN is responsible for the entirety of the company's active office actions. This focus means that the company's immediate patent strategy is dependent on this one examiner's evaluation.
The involvement of 1 distinct art unit for the 1 pending office action indicates a specific technical focus for the company's current patent applications. With 1 pending office action representing the total volume of the portfolio's active prosecution, the company's immediate IP goals are tied to a single examiner's review. This focus in the Medical Devices & Mechanical Engineering sector allows for a direct prosecution strategy, though it lacks the diversification found in larger portfolios.
By focusing resources on the 1 pending office action with 1 distinct examiner, the company can maintain oversight on its intellectual property development. The outcome of this matter is the primary factor in the company's immediate success in the US patent system. This concentrated profile in 1 distinct art unit suggests a specific technological niche for the company's current filings. SISON, CHRISTINE ANDREA PAN handles the busiest_examiner_pending count of 1.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SISON, CHRISTINE ANDREA PAN | 1 | 32.7% | +40.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19001366 | LASER ABLATION METHOD, APPARATUS AND DEVICE, AND COMPUTER READABLE STORAGE MEDIUM | SISON, CHRISTINE ANDREA PAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19001366 | LASER ABLATION METHOD, APPARATUS AND DEVICE, AND COMPUTER READABLE STORAGE MEDIUM | SISON, CHRISTINE ANDREA PAN | — |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19001366 | LASER ABLATION METHOD, APPARATUS AND DEVICE, AND COMPUTER READABLE STORAGE MEDIUM | SISON, CHRISTINE ANDREA PAN | 3796 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHangzhou Genlight Neurotech Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Christine Andrea Pan Sison has the most, with 1 of Hangzhou Genlight Neurotech Co. Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
